arrow_back Back to App

Scheduling of Fentanyl-Related Substances and Expedited Research Procedures

This bill amends the Controlled Substances Act to place fentanyl-related substances into Schedule I based on specific chemical structural modifications. It also establishes expedited registration procedures for practitioners conducting research with Schedule I substances, allows for single registration across multiple sites within the same institution, and permits certain manufacturing activities coincident to research.
Key points
Defines "fentanyl-related substances" based on chemical structure and adds them to Schedule I of the Controlled Substances Act.
Creates expedited registration procedures for researchers conducting studies with Schedule I substances.
Allows researchers to conduct research at multiple sites under a single registration and manufacture small quantities of substances for research purposes.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_S_1141
Sponsor: Sen. Cassidy, Bill [R-LA]
Process start date: 2023-03-30
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-3-pro-preview
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

HALT Fentanyl Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_S_1141.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2023-03-30.

What are the main provisions?

Key points include:

  • Defines "fentanyl-related substances" based on chemical structure and adds them to Schedule I of the Controlled Substances Act.
  • Creates expedited registration procedures for researchers conducting studies with Schedule I substances.
  • Allows researchers to conduct research at multiple sites under a single registration and manufacture small quantities of substances for research purposes.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Cassidy, Bill [R-LA].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-30.

CATEGORIES

Health Courts and Law